Kailera Therapeutics, Inc. · NASDAQ:KLRA

Koppel Adam bought 1,562,500 Kailera Therapeutics, Inc. shares (Form 4)

Traded Apr 20, 2026 · Filed Apr 20, 2026

On Apr 20, 2026, Koppel Adam (Director, 10% owner) bought 1,562,500 Kailera Therapeutics, Inc. shares at US$16.00 for US$25M, leaving 22,583,268 shares. Filed Apr 20, 2026 (Form 4).

Bought
1,562,500 shares
Price
US$16.00
Value
US$25M
Holding after
22,583,268 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 20, 2026Common StockConversion16,875,00016,875,000Indirect
Apr 20, 2026Common StockConversion4,145,76821,020,768Indirect
Apr 20, 2026Common StockBuy1,562,500US$16.0022,583,268Indirect

Source

View original at SEC

Related